First-level Neurocognitive Screening Tests and their Application
Journal Title: Journal of Regenerative Biology and Medicine - Year 2021, Vol 3, Issue 5
Abstract
In June 2021, the Food and Drug Administration approved Aducanumab for the treatment of Alzheimer’s disease – the most common cause of dementia worldwide [1]. This drug is a monoclonal antibody that would be cause amyloid-β plaques reduction in the brain [2]. Whether its effectiveness will be confirmed or not, the fact remains that the patients that will benefit the most from any treatment are the ones suffering from mild NCD. Mild NCD is a clinically insidious and difficult-to-diagnose disorder, and consequently, the development and the spread of screening methods are necessary to early intercept these subjects.
Authors and Affiliations
Francesco Salis*, Antonella Mandas
Keywords
Related Articles
- EP ID EP707387
- DOI https://doi.org/10.37191/Mapsci-2582-385X-3(5)-083
- Views 77
- Downloads 0
Front-line Healthcare Workers in COVID-19: The way from Elbow-Bump Greeting to Closing Body Bags
COVID-19 is a serious coronavirus disease that is spreading all over the world. As of the date of this publication, 2.834.134 people have been infected with COVID-19 and 197.924 deaths have been recorded in 185 countries...
COVID-19 in Adults and Children: The Clock is Ticking
COVID-19 the world is shocked. Globally, 896450 confirmed cases and 45525 deaths (WHO, situation report 73, 2 April 2020) reveal that a viral agent is spreading in an exponential way all around the world with to date unk...
Effect of Saudi and Egyptian Pomegranate Polyphenols in Regulating the Activity of Pon1, Pon2 and Lipid Profile for Preventing Coronary Heart Disease
Saudi and Egyptian pomegranate juice (APJ and EPJ) contains potent polyphenols, antioxidants that were found to reduce serum and macrophage oxidative stress. The protective effects of APJ and EPJ against atherogenicity w...
Relentless Regeneration
Regenerative Medicine is a branch of medicine holding promise for the repair of cells, tissues, and organs to effective function. Much of the field has been developed in response to damage sustained by injury and disease...
Can IV Infusions of Bone Marrow Derived Mesenchymal Stem Cell Extracellular Vesicles be the Fountain of Youth?
There is increasing published literature to support the safety and efficacy of IV infusions of bone marrow-derived expanded allogeneic mesenchymal stem cells (MSCs) for the treatment of various auto-immune diseases. Frai...